Belgium vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Antiretroviral therapy coverage
Belgium
88.0%
in 2023
Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
26.5%
in 2024
Belgium rank
23rd
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank
22nd
Antiretroviral therapy coverage over time
- Belgium
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
How they compare
Belgium currently reports 88.0% against 26.5% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 61.5%.
That makes Belgium's figure about 3.3 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.
Across all 24 years both countries report, Belgium has been ahead every year.
Belgium ranks 23rd and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 22nd of 143 countries.
Belgium has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belgium | Middle East, North Africa, Afghanistan & Pakistan (excluding high income) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 54.8% | 3.4% | 51.4% | Belgium |
| 2010s | 85.0% | 12.8% | 72.2% | Belgium |
| 2020s | 87.8% | 22.3% | 65.5% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Belgium or Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- Belgium, at 88.0% against 26.5% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2023.
- What is the difference in antiretroviral therapy coverage between Belgium and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- 61.5%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- 24 years are reported by both, from 2000 to 2023.
- How do Belgium and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank globally for antiretroviral therapy coverage?
- Belgium ranks 23rd and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 22nd of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.